Clinical Trial Update: Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on hetrombopag for non-severe aplastic anemia across Phase 2 and Phase 3 assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anemia, Drug Effect | Phase 2, Phase 3 | Status: UNKNOWN